Home > Insider Trading > Filing (0000899243-17-010925)

Filing Details

Accession Number:: 0000899243-17-010925
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-04-26 17:59:22
Reporting Period:: 2017-04-24

Filing Date:: 2017-04-26
Accepted Time:: 2017-04-26 17:59:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
861838	Idera Pharmaceuticals Inc.	IDRA	Biological Products, (No Disgnostic Substances) (2836)	043072298

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1193366	El Youssef Zein	Pillar Invest Offshore Sal Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	Yes	No	Yes	No
1534425	Pillar Pharmaceuticals I Lp	Pillar Invest Offshore Sal, Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	Yes	No	Yes	No
1534428	Pillar Invest Corp	C/O Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139	Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-04-24	437,829	$2.29	0	No	4	S	Indirect	See footnotes
Common Stock	Disposition	2017-04-25	890,593	$2.29	0	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Footnotes

The sales reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Persons.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $2.25-$2.353. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"), of which Pillar Invest Corporation ("Pillar GP") is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. As of the date hereof and following the transactions reported herein, Pillar I owns directly 2,131,703 shares of common stock of the Issuer.
Youssef El Zein is a director and controlling stockholder of Pillar GP and serves as the representative of Pillar I and Pillar GP on the Issuer's board of directors. Mr. El Zein disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that he is the beneficial owners of any such securities, except to the extent of his pecuniary interest therein, if any, by virtue of his ownership interest in Pillar GP. As of the date hereof, Mr. El Zein owns directly 528,538 shares of common stock of the Issuer.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $2.27-$2.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.